Startup profile · funding coverage
Scarlet funding, valuation and investors
AI-native certification body for software and AI medical devices.
Keep track of Scarlet
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series B
$50M · October 12, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$68M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series b · London, United Kingdom
Investors in latest funding
Lead: Headline
Other: Notion Capital , Atomico , Creandum , Kindred Capital , Entrepreneurs First
Overview
Scarlet is a London-based, government-designated certification body specializing in software and AI medical devices. Its platform combines qualified human reviewers with AI-assisted document assessment and continuous surveillance to shorten certification and product-update cycles across the UK, European Union and United States.
Why Scarlet is interesting
Scarlet is building regulatory infrastructure for continuously changing medical software—a bottleneck that grows as AI models iterate faster than conventional device certification workflows.
Product & use cases
Manufacturers submit technical documentation to Scarlet for assessment against medical-device and management-system standards. Qualified reviewers make certification decisions while Scarlet's software supports document analysis, ongoing surveillance, annual audits and product changes.
- Certification of AI and software-based medical devices.
- Continuous surveillance and annual audits for certified products.
- Assessment of product updates as AI-enabled devices evolve.
Key facts
- UK Approved Body for medical devices, listed by the MHRA as body 8536.
- EU notified body for medical devices, listed as Scarlet NB B.V. body 3022.
- FDA-recognized third-party review organization for eligible 510(k) submissions.
Funding history (newest first)
Investors in our directory
Funds linked from Scarlet's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Scarlet combines formal regulatory designations with a software-first workflow built specifically for AI and software medical devices rather than broad product categories.
Scarlet competes with established conformity-assessment organizations such as BSI, TÜV SÜD and DEKRA. Its differentiation is specialization in software and AI, but regulatory credibility, reviewer capacity and cross-border recognition remain the decisive constraints.
-
BSI incumbent
Large global standards and certification organization with broad medical-device coverage.
-
TÜV SÜD incumbent
Global testing and certification group active across medical devices and many other regulated products.
-
DEKRA incumbent
International testing, inspection and certification provider with medical-device capabilities.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Scarlet's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.